We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

30 hedge funds and large institutions have $6.98M invested in CERo Therapeutics Warrants in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+30
Holders Change %
–
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
–
Reduced
–
Closed
–
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
+$57K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$173K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$138K
3
SCM
Saba Capital Management
New York
+$136K
4
AA
AQR Arbitrage
Connecticut
+$115K
5
ACM
Atalaya Capital Management
New York
+$104K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
1
AQR Arbitrage
Connecticut
$2.48M +$115K +249,998 New
MP
2
Mangrove Partners
Connecticut
$1.62M +$75.4K +163,538 New
RCM
3
Radcliffe Capital Management
Pennsylvania
$1.49M +$69.2K +150,000 New
HCM
4
Highbridge Capital Management
New York
$198K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$162K +$173K +375,000 New
CF
6
Cantor Fitzgerald
New York
$158K +$173K +375,000 New
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$126K +$138K +300,000 New
SCM
8
Saba Capital Management
New York
$124K +$136K +295,913 New
ACM
9
Atalaya Capital Management
New York
$95K +$104K +225,000 New
FTCM
10
Fir Tree Capital Management
New York
$54K +$57.6K +125,000 New
MI
11
MMCAP International
Cayman Islands
$53K +$57.6K +125,000 New
SCM
12
Segantii Capital Management
Hong Kong
$50K +$2.31K +5,000 New
CL
13
CSS LLC
Illinois
$50K +$54.8K +118,894 New
NAM
14
Nexpoint Asset Management
Texas
$46K +$50.1K +108,741 New
CH
15
CVI Holdings
Delaware
$42K +$45.1K +97,750 New
QGA
16
Q Global Advisors
Texas
$42K +$46.1K +100,000 New
WAM
17
Wolverine Asset Management
Illinois
$33K +$37.2K +80,689 New
KPF
18
K2 Principal Fund
Ontario, Canada
$32K +$34.6K +75,000 New
SCC
19
Spring Creek Capital
Kansas
$22K +$23.1K +50,000 New
TCM
20
Tenor Capital Management
New York
$21K +$23.1K +50,000 New
HF
21
HRT Financial
New York
$15K +$16.6K +36,000 New
Hudson Bay Capital Management
22
Hudson Bay Capital Management
Connecticut
$13K +$13.8K +30,000 New
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$11K +$11.5K +25,000 New
WA
24
Whitebox Advisors
Minnesota
$11K +$11.5K +25,000 New
RCM
25
Rivernorth Capital Management
Florida
$10K +$11.5K +24,998 New
1
2

CEROW Hedge Fund Activity: Q4 2021 in Review

30 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2021, worth a combined $6.98M.

Buyers outnumbered sellers: 30 funds opened new CEROW positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $173K.

  • 30 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $6.98M of CERo Therapeutics Warrants stock for Q4 2021.
  • 30 funds opened new CERo Therapeutics Warrants positions in Q4 2021 and 0 closed out, a net change of +30 holders.
  • The largest CERo Therapeutics Warrants buyer in Q4 2021 was Citadel Advisors, an estimated $173K added.

Based on aggregated 13F filings for Q4 2021.